Clinical Trials
Lung Cancer
Protocol No. 20070782: A Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Long-term Safety and Efficacy of Darbepoetin Alfa Administered at 500 mg Once-Every-3-Weeks in Anemic Subjects with Advanced Stage Non-small Cell Lung Cancer Receiving Multi-cycle Chemotherapy.
- Principal Investigator: Scott A. Sonnier, MD
Start-EMR63325-001: A multi-center phase III randomized, double-blind placebo-controlled study of the cancer vaccine Stimuvax(R) in non-small cell lung cancer (NSCLS) subjects with unresectable stage III disease.
- Principal Investigator: S. Caputto, MD
